M&A Deal Summary

Arranta Bio Acquires Captozyme

On November 13, 2019, Arranta Bio acquired life science company Captozyme

Acquisition Highlights
  • This is Arranta Bio’s 1st transaction in the Life Science sector.
  • This is Arranta Bio’s 1st transaction in the United States.
  • This is Arranta Bio’s 1st transaction in Florida.

M&A Deal Summary
Date 2019-11-13
Target Captozyme
Sector Life Science
Buyer(s) Arranta Bio
Deal Type Add-on Acquisition

Target

Captozyme

Gainesville, Florida, United States
Captozyme, Inc. is a process development and clinical contract manufacturing for the microbiome. Captozyme was founded in 2016 and is based in Gainesville, Florida.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Arranta Bio

Watertown, Massachusetts, United States
Category Company
Founded 2019
Sector Life Science
DESCRIPTION

Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. Arranta Bio was founded in 2019 and is based in Watertown, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Florida) 1 of 1
Country (United States) 1 of 1
Year (2019) 1 of 1
Mergr

Product

Company

Legal